asuragen/QuantideX®NGS DNA热点21试剂盒/48/76044

价格
面议
货号:76044
浏览量:127
品牌:asuragen
服务
全国联保
正品保证
正规发票
签订合同
商品描述

QuantideX® NGS DNA Hotspot 21 Kit

The QuantideX® NGS DNA Hotspot 21 Kit (RUO) is a next generation sequencing (NGS) research tool that interrogates 46 hotspot regions (amplicons) within 21 genes that are commonly mutated in a number of solid and hematological malignancies.  The kit detects over 1,500 known variants, including single nucleotide variants (SNVs), insertions/deletions (indels), and structural rearrangements.  Leveraging our proprietary NGS-in-a-Box™ workflow and Sample-Aware™ bioinformatics quality control solutions, this kit provides a simple, robust, and reliable NGS assay for the routine investigation of these genomic variants.

Features & Benefits

The QuantideX NGS DNA Hotspot 21 Kit combines Asuragen’s unique NGS-in-a-Box™ solution with a streamlined testing workflow to enable unprecedented NGS workflow efficiency and high sensitivity at low input amounts from precious FFPE samples.

Reduced ComplexityAssay incorporates sample-to-data solutions in a unique NGS-in-a-Box™ configuration

  • Detects >1,500 variants from commonly mutated genomic regions across multiple tumor types
  • End-to-end kitted solution
  • Fully integrated data analysis pipeline

Optimized WorkflowProvides operational efficiencies to reduce testing costs, hands-on and total turnaround time

  • Reduced labor required for library preparation
  • Improved turnaround time enables higher throughput
  • Common workflow across portfolio streamlines training & implementation

Quality PerformanceHighly sensitive assay with integrated, Sample-Aware™ bioinformatics software and built-in quality checks to minimize erroneous results and sample failures

  • Highly sensitive detection of DNA-based variants
  • Low input (~20ng) of DNA from FFPE
  • Sample-Aware™ bioinformatics analysis and sample quality control

Product Description

Relevant ContentThe QuantideX NGS DNA Hotspot 21 Kit detects over 1,500 genomic variants as reported in the Catalogue of Somatic Mutations in Cancer (COSMIC) Database within 21 genes, representing approximately 80% of known variants within these targets.

Table 1: Mutation coverage of QuantideX NGS DNA Hotspot 21 Kit

Table 2: Clinical relevance of covered mutations

1NCCN Clinical Practice Guidelines*Includes gastric, pancreatic, glicomas, sarcomas, and other tumor types

A Fully Integrated WorkflowA unique NGS-in-a-Box™ configuration offers a simplified and fully integrated NGS workflow with cGMP-manufactured reagents, components and controls ready to use.

Includes:

  • An internal quality control kit to measure the absolute copy number of amplifiable DNA and reports PCR inhibition
  • Gene-specific PCR primers and Master Mix reagents
  • Dual-index barcodes for sample multiplexing
  • Library purification and quantification reagents
  • Integrated data analysis and reporting software (QuantideX NGS Reporter)

Rapid & EfficientAdopt and run NGS-based analysis with minimum investment of time and resources, regardless of NGS experience and infrastructure.

  • Fully integrated workflow reduces complexity and ensures reliable reagent quality
  • Push-button analysis & reporting makes bioinformatics easy and efficient, regardless of experience level
  • Integrated kit reduces overall workflow time

Performance Data

Highly Sensitive and Accurate Detection of DNA Mutations

QuantideX® NGS Reporter

Push-button analytics & reporting suite – Set-up-and-go workflow designed for easy installation and implementation, right out of the box.

Operates on a standard desktop computer – Install locally on a desktop computer using Windows® operating system.  No prior bioinformatics experience or large server environments required.

Comprehensive– Full bioinformatics and reporting of variants (SNVs, Indels), and standard QC metrics are automatically calculated.

Integrates Sample-Aware – Bioinformatics with integrated functional template copy number analysis dramatically reduces false-call rates.

Resources

Videos

Next-Generation Sequencing Within Your Reach: Implementation of an Actionable Mutation Panel for Molecular Oncology Testing

Posters

Analytical Validation Of The QuantideX® NGS DNA Hotspot 21 Kit, A Diagnostic NGS System for the Detection of Actionable Mutations in FFPE TumorsView full poster

A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX® NGS DNA Hotspot 21 KitView full poster

A Simple and Versatile Next-Generation Sequencing Technology for Co-Detection of RNA Structural Variants and DNA Mutations in Lung CancerView full poster 

Ordering

Product NameNumber of ReactionsCatalog Number
QuantideX NGS DNA Hotspot 21 Kit*4846108

T 1.877.777.1874 | 512.681.5200 F 512.681.5202 E orders@asuragen.com

View Sales Contacts

*For Research Use Only. Not for use in Diagnostic procedures.

QuantideX® NGS DNA Hotspot 21 Kit

The QuantideX® NGS DNA Hotspot 21 Kit is an in vitro diagnostic, next-generation sequencing (NGS) panel for the detection of clinically relevant variants across a multitude of tumor types, including non-small cell lung cancer, colorectal cancer, and melanoma.  The kit screens for over 1,500 known genomic variants, including single nucleotide variants (SNVs), insertions/deletions (indels), and structural rearrangements, many of which are treatable with novel therapies, inform on patient management, or are the subject of further clinical evaluation.  Leveraging our proprietary NGS-in-a-Box™ workflow and Sample-Aware™ bioinformatics quality control solutions, the panel provides a robust and reliable NGS solution for the identification of clinically relevant targets you and your clinicians can trust.

Features & Benefits

The QuantideX NGS DNA Hotspot 21 Kit combines Asuragen’s unique NGS-in-a-Box™ solution with a streamlined testing workflow to enable unprecedented NGS workflow efficiency and high sensitivity at low input amounts from precious FFPE samples.

Reduced ComplexityAssay incorporates sample-to-data solutions in a unique NGS-in-a-Box™ configuration

  • Detects >1,500 variants from commonly mutated genomic regions across multiple tumor types
  • End-to-end kitted solution
  • Fully integrated data analysis pipeline

Optimized WorkflowProvides operational efficiencies to reduce testing costs, hands-on and total turnaround time

  • Reduced labor required for library preparation
  • Improved turnaround time enables higher throughput
  • Common workflow across portfolio streamlines training & implementation

Quality PerformanceHighly sensitive assay with integrated, Sample-Aware™ bioinformatics software and built-in quality checks to minimize erroneous results and sample failures

  • Highly sensitive detection of DNA-based variants
  • Low input (~20ng) of DNA from FFPE
  • Sample-Aware™ bioinformatics analysis and sample quality control

Product Description

Relevant ContentThe QuantideX NGS DNA Hotspot 21 Kit detects over 1,500 genomic variants as reported in the Catalogue of Somatic Mutations in Cancer (COSMIC) Database within 21 genes, representing approximately 80% of known variants within these targets.  Several of these variants are associated with approved therapies, while others are currently in trials to clarify their clinical significance.

Table 1: Mutation coverage of QuantideX NGS DNA Hotspot 21 Kit

Table 2: Clinical relevance of covered mutations

1NCCN Clinical Practice Guidelines*Includes gastric, pancreatic, glicomas, sarcomas, and other tumor types

A Fully Integrated WorkflowA unique NGS-in-a-Box™ configuration offers a simplified and fully integrated NGS workflow with cGMP-manufactured reagents, components and controls ready to use.

Includes:

  • An internal quality control kit to measure the absolute copy number of amplifiable DNA and reports PCR inhibition
  • Gene-specific PCR primers and Master Mix reagents
  • Dual-index barcodes for sample multiplexing
  • Library purification and quantification reagents
  • Integrated data analysis and reporting software (QuantideX NGS Reporter)

Rapid & EfficientAdopt and run NGS-based analysis with minimum investment of time and resources, regardless of NGS experience and infrastructure.

  • Fully integrated workflow reduces complexity and ensures reliable reagent quality
  • Push-button analysis & reporting makes bioinformatics easy and efficient, regardless of experience level
  • Integrated kit reduces overall workflow time

Performance Data

Highly Sensitive and Accurate Detection of DNA Mutations

QuantideX® NGS Reporter

Push-button analytics & reporting suite – Set-up-and-go workflow designed for easy installation and implementation, right out of the box.

Operates on a standard desktop computer – Install locally on a desktop computer using Windows® operating system.  No prior bioinformatics experience or large server environments required.

Comprehensive – Full bioinformatics and reporting of variants (SNVs, Indels) and standard QC metrics are automatically calculated.

Integrates Sample-Aware – bioinformatics with integrated functional template copy number analysis dramatically reduces false-call rates.

Resources

Videos

Next-Generation Sequencing Within Your Reach: Implementation of an Actionable Mutation Panel for Molecular Oncology Testing

Posters

Analytical Validation Of The QuantideX® NGS DNA Hotspot 21 Kit, A Diagnostic NGS System for the Detection of Actionable Mutations in FFPE TumorsView full poster

A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX® NGS DNA Hotspot 21 KitView full poster

A Simple and Versatile Next-Generation Sequencing Technology for Co-Detection of RNA Structural Variants and DNA Mutations in Lung CancerView full poster 

Ordering

Product NameNumber of ReactionsCatalog Number
QuantideX NGS DNA Hotspot 21 Kit*4876044

T 1.877.777.1874 | 512.681.5200 F 512.681.5202 E orders@asuragen.com

View Sales Contacts

*For Research Use Only. Not for use in Diagnostic procedures.

asuragen的AmplideX®PCR / CE HTT试剂盒 AmplideX PCR / CE  HTT 试剂盒*使HTT  基因中CAG三核苷酸重复序列的检测和确定  比以往更加容易。只需一次PCR反应,该测定法即可克服相邻SNP的挑战,可变的CCG重复序列可准确可靠地报告一天中重复序列的数量,从10ng gDNA即可。  特点与优势分析特性订购信息特点与优势AmplideX PCR / CE HTT试剂盒包含用于对HTT CAG重复区域进行两引物,锚定引物PCR的试剂,然后通过毛细管电泳确定片段大小。这种单管PCR反应提供了简化的工作流程,使用现成的实验室设备可以在大约6小时内得到样品。降低复杂度专有的PCR解决方案,用于富含GC的扩增和检测消除了对多个PCR的需求–一个结果,简单的分析解决接合性并检测大扩展优化的工作流程配套齐全的端到端解决方案,可大大减少动手时间一次转换即可实现样品到结果与AmplideX PCR / CE DMPK试剂盒相同的PCR和CE条件质量结果可靠,明确的结果和稳定的峰峰值模式在整个CAG重复范围内准确调整大小软件将原始碱基对数据转换为重复数